Molina Healthcare (NYSE:MOH – Get Free Report) had its price target cut by Wells Fargo & Company from $235.00 to $220.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price would indicate a potential upside of 10.07% from the company’s previous close.
MOH has been the subject of a number of other research reports. Robert W. Baird upped their price objective on Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Morgan Stanley lifted their target price on Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 4th. Zacks Research raised shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 23rd. Sanford C. Bernstein set a $286.00 price target on shares of Molina Healthcare in a research report on Monday, July 13th. Finally, Barclays decreased their price objective on shares of Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating for the company in a report on Friday. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $202.44.
Read Our Latest Stock Analysis on MOH
Molina Healthcare Stock Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.12. The firm had revenue of $10.87 billion for the quarter, compared to the consensus estimate of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The company’s revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.48 EPS. Equities research analysts forecast that Molina Healthcare will post 5.31 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the sale, the insider owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by corporate insiders.
Institutional Trading of Molina Healthcare
A number of institutional investors have recently added to or reduced their stakes in the stock. Torren Management LLC purchased a new stake in shares of Molina Healthcare in the fourth quarter worth about $26,000. Physician Wealth Advisors Inc. grew its position in Molina Healthcare by 1,250.0% in the first quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock worth $29,000 after acquiring an additional 200 shares in the last quarter. Cromwell Holdings LLC boosted its holdings in shares of Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after purchasing an additional 125 shares in the last quarter. Quarry LP bought a new position in Molina Healthcare during the fourth quarter valued at approximately $32,000. Finally, SJS Investment Consulting Inc. grew its holdings in shares of Molina Healthcare by 504.9% during the 1st quarter. SJS Investment Consulting Inc. now owns 248 shares of the company’s stock valued at $33,000 after purchasing an additional 207 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Recommended Stories
- Five stocks we like better than Molina Healthcare
- Middleby Is Betting a Leaner Business Can Unlock More Value
- 3 Value ETFs to Consider as Growth Stocks Lag Behind
- Wintrust: A Quiet Regional Bank Posting Loud Results
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
